<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>1932494</identifier>
<setSpec>0212-7199</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Diéguez Gómez, P</dc:author>
<dc:author>Meniño Olveira, M J</dc:author>
<dc:author>Casal Iglesias, L</dc:author>
<dc:author>Cutrin Prieto, C</dc:author>
<dc:author>Batalla Eiras, A</dc:author>
<dc:author>Lorenzo Zúniga, V</dc:author>
<dc:description xml:lang="en">A 79 year old patient with a previous history of 10 months of mucous diarrhea is admitted due to pre-renal insufficiency, hyponatremia, hypokalemia and metabolic alkalosis secondary to rectal villous adenoma. The volume of the rectal discharge was 2.500 cc/day. Sodium level of the rectal secretion was 145 mEq/L and potassium 20 mEq/L. E2 prostaglandin: 1500 pg/ml. After hydroelectrolytic treatment, a PG synthetase inhibitor (indomethacin) was added to a dosage of 25 mg q/d PO. Rectal discharge was reduced to 500 cc/day, as well as sodium and prostaglandin levels. It has been proved that the use of PG synthetase inhibitors can facilitate the preparatory metabolic control in patients with villous adenoma.</dc:description>
<dc:type>Case Reports</dc:type>
<dc:language>es</dc:language>
<dc:date>1991 Jul </dc:date>
<dc:title xml:lang="es">Tratamiento con indometacina para el control del trastorno metabólico producido por un adenoma velloso de recto.</dc:title>
<dc:title xml:lang="en">[Treatment with indomethacin for the control of the metabolic disorder caused by a villous adenoma of the rectum].</dc:title>
<dc:publisher>Anales de medicina interna (Madrid, Spain : 1984)</dc:publisher>
</metadata>
</record>
</pubmed-document>
